We may be starting a fire only to try putting it out with a water gun.

Raffaele Giusti· @oncoblogger · X·2026-10-24 14:52· 2 days agoScore45

Body

Managing skin toxicity matters. But how certain are we that our mitigation strategies are sufficient, and that the overall balance of benefits and harms remains favorable?

#ESMO26 #LungCancer #Amivantamab

8 views · 1 like · 0 reposts · 0 replies

Conference abstracts

2700ROmatched by Rapid oral 1: NSCLC, metastatic

Improving prevention of moderate to severe dermatologic adverse events in EGFR-mutant advanced NSCLC treated with first-line (1L) subcutaneous (SC) amivantamab + lazertinib: First results from a new COCOON cohort

https://esmocongress.esmo.org

NCT06385080NCT06385080matched by - **标题 / Title：** A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

- **标题 / Title：** A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

https://esmocongress.esmo.org

NCT07276399NCT07276399matched by - **标题 / Title：** A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

- **标题 / Title：** A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

https://esmocongress.esmo.org

Source: Raffaele Giusti · x.com